
    
      Study approval: The study was submitted for approval by Scientific and Ethical Committee at
      Faculty of Medicine, Sohag University. An informed written consent will be obtained from all
      participants.

      Study design: randomized controlled trial. Study population: the study will include patients
      who attend the outpatient Clinic of Dermatology & Venereology and Andrology, Faculty of
      Medicine, Sohag University in corporation with Farshot General Hospital. Women who are
      pregnant or lactating, children aged 2 years or less and patients with acute or chronic
      disease that might affect skin barrier function will be excluded.

      Patients and methods:

      Study participants will be randomly divided into two treatment groups: group A will receive
      0.03% tacrolimus ointment and group B will receive hydrocortisone acetate 1% ointment twice
      daily for 6 months.

      Patients will be evaluated at baseline and monthly intervals for 6 months and at 3 months
      after stopping treatment.
    
  